D. M. Mota

发表

[Evaluation of the Performance of the Brazilian Notification System for Health Surveillance: A Tool in Brazil's Pharmacovigilance System].

Á. Vigo, R. Kuchenbecker, D. M. Mota, 2020, Ciencia & saude coletiva.

Data Sources for Drug Utilization Research in Brazil—DUR-BRA Study

M. Elseviers, L. Lopes, C. Osorio-de-Castro, 2022, Frontiers in Pharmacology.

Regulatory Impact Assessment in pandemic times: a practical exercise in the COVID-19 context

D. M. Mota, Flavio Saab, Raisa Zandonade Vazzoler, 2020 .

Considerations on the use of scientific evidences in times of a pandemic: the case of COVID-19

R. Kuchenbecker, D. M. Mota, 2020 .

[Recommendation of ICD-10 codes for surveillance of adverse drug reactions and drug intoxication].

Á. Vigo, R. Kuchenbecker, D. M. Mota, 2018, Ciencia & saude coletiva.

The Use of the Target Trial Approach in Perinatal Pharmacoepidemiology: A Scoping Review Protocol

G. Gore, R. Platt, D. M. Mota, 2022, Frontiers in Pharmacology.

[Profile of mortality by intoxication with medication in Brazil, 1996-2005: portrait of a decade].

D. M. Mota, Daniel Roberto Coradi de Freitas, J. R. R. Melo, 2012, Ciencia & saude coletiva.

[Are there irrationalities in the consumption of anti-obesity drugs in Brazil? A pharmaco-econometric analysis of panel datasets].

Sidarta Figueredo Silva, J. A. Divino, D. M. Mota, 2014, Ciencia & saude coletiva.

[Investigation in field pharmacoepidemiology: a proposal for the actions of pharmacovigilance in Brazil].

D. M. Mota, 2011, Revista brasileira de epidemiologia = Brazilian journal of epidemiology.

Evolution and key elements of the Brazilian pharmacovigilance system: a scoping review beginning with the creation of the Brazilian Health Regulatory Agency.

Á. Vigo, R. Kuchenbecker, D. M. Mota, 2018, Cadernos de saude publica.

Isolation and partial characterisation of highly toxic lectins from Abrus pulchellus seeds.

B. Cavada, M. V. Ramos, R. Moreira, 1998, Toxicon : official journal of the International Society on Toxinology.

Causality in Pharmacoepidemiology and Pharmacovigilance: a theoretical excursion.

R. Kuchenbecker, D. M. Mota, 2017, Revista brasileira de epidemiologia = Brazilian journal of epidemiology.

[Evaluation of the System of Sanitary Vigilance of Blood at the federal level, Brazil, 2007].

Daniel Marques Mota, Daniel Roberto Coradi Freitas, Wildo Navegantes de Araújo, 2012, Ciencia & saude coletiva.

[Evidence for the use of appetite suppressant drugs in Brazil: a pharmacoeconometric study].

D. M. Mota, Gilson Geraldino Silva, 2012, Revista da Associacao Medica Brasileira.

[Adverse drug reactions reported to the Brazilian pharmacovigilance system from 2008 to 2013: descriptive study].

Á. Vigo, R. Kuchenbecker, D. M. Mota, 2019, Cadernos de saude publica.

Miracle drug: Brazil approves never-tested cancer medicine

R. Kuchenbecker, D. M. Mota, 2017, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.